Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy

Frontiers in Bioscience

Volumn 14, Issue 12, 2009, Pages 4778-4792

  Love, Seth ^a,b   Miners, Scott ^a   Palmer, Jen ^a   Chalmers, Katy ^a   Kehoe, Patrick ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

Alzheimer's disease; Amyloid peptide; Angiotensin converting enzyme; Apolipoprotein E; Cerebral amyloid angiopathy; Endothelin converting enzyme; Extracellular matrix; Insulin degrading enzyme; Neprilysin; Plasmin; Transforming growth factor 1

Indexed keywords

GENETIC PREDISPOSITION; GENETICS; HUMAN; REVIEW; RISK FACTOR; VASCULAR AMYLOIDOSIS;

CEREBRAL AMYLOID ANGIOPATHY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RISK FACTORS;

EID: 63849115094     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3567     Document Type: Article

References (135)

1. Revesz, T., J. L. Holton, T. Lashley, G. Plant, A. Rostagno, J. Ghiso & B. Frangione: Sporadic and familial cerebral amyloid angiopathies. Brain Pathol, 12, 343-57(2002) (Pubitemid 34743217)
2. Revesz, T., J. Ghiso, T. Lashley, G. Plant, A. Rostagno, B. Frangione & J. L. Holton: Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view. J Neuropathol Exp Neurol, 62, 885-98(2003) (Pubitemid 37159029)
3. Esiri, M. M. & G. K. Wilcock: Cerebral amyloid angiopathy in dementia and old age. J Neurol Neurosurg Psychiatry, 49, 1221-6(1986) (Pubitemid 17174021)
4. Premkumar, D. R., D. L. Cohen, P. Hedera, R. P. Friedland & R. N. Kalaria: Apolipoprotein E-ε4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol, 148, 2083-95(1996)
5. Chalmers, K., G. K. Wilcock & S. Love: APOE ε4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of Aβ protein. Neuropathol Appl Neurobiol, 29, 231-8(2003) (Pubitemid 36718171)
6. Love, S., J. A. Nicoll, A. Hughes & G. K. Wilcock: APOE and cerebral amyloid angiopathy in the elderly. Neuroreport, 14, 1535-6(2003) (Pubitemid 37083144)
7. Van Dorpe, J., L. Smeijers, I. Dewachter, D. Nuyens, K. Spittaels, C. Van DenHaute, M. Mercken, D. Moechars, I. Laenen, C. Kuiperi, K. Bruynseels, I. Tesseur, R. Loos, H. Vanderstichele, F. Checler, R. Sciot & F. Van Leuven: Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons. Am J Pathol, 157, 1283-98(2000)
8. Burgermeister, P., M. E. Calhoun, D. T. Winkler & M. Jucker: Mechanisms of cerebrovascular amyloid deposition. Lessons from mouse models. Ann N Y Acad Sci, 903, 307-16(2000) (Pubitemid 30251571)
9. Helisalmi, S., M. Hiltunen, S. Vepsalainen, S. Iivonen, A. Mannermaa, M. Lehtovirta, A. M. Koivisto, I. Alafuzoff & H. Soininen: Polymorphisms in neprilysin gene affect the risk of Alzheimer's disease in Finnish patients. J Neurol Neurosurg Psychiatry, 75, 1746-8(2004) (Pubitemid 39611478)
10. Mackic, J. B., M. Stins, J. G. McComb, M. Calero, J. Ghiso, K. S. Kim, S. D. Yan, D. Stern, A. M. Schmidt, B. Frangione & B. V. Zlokovic: Human blood-brain barrier receptors for Alzheimer's amyloid-β1-40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. J Clin Invest, 102, 734-43(1998) (Pubitemid 28399606)
11. Deane, R., S. Du Yan, R. K. Submamaryan, B. LaRue, S. Jovanovic, E. Hogg, D. Welch, L. Manness, C. Lin, J. Yu, H. Zhu, J. Ghiso, B. Frangione, A. Stern, A. M. Schmidt, D. L. Armstrong, B. Arnold, B. Liliensiek, P. Nawroth, F. Hofman, M. Kindy, D. Stern & B. Zlokovic: RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain. Nat Med, 9, 907-13(2003) (Pubitemid 36889934)
12. Fukuchi, K., L. Ho, S. G. Younkin, D. D. Kunkel, C. E. Ogburn, R. C. LeBoeuf, C. E. Furlong, S. S. Deeb, D. Nochlin, J. Wegiel, H. M. Wisniewski & G. M. Martin: High levels of circulating β-amyloid peptide do not cause cerebral β-amyloidosis in transgenic mice. Am J Pathol, 149, 219-27(1996) (Pubitemid 26230993)
13. Kalaria, R. N., D. R. Premkumar, A. B. Pax, D. L. Cohen & I. Lieberburg: Production and increased detection of amyloid β protein and amyloidogenic fragments in brain microvessels, meningeal vessels and choroid plexus in Alzheimer's disease. Brain Res Mol Brain Res, 35, 58-68(1996) (Pubitemid 26036732)
14. Prior, R., G. Wihl & B. Urmoneit: Apolipoprotein E, smooth muscle cells and the pathogenesis of cerebral amyloid angiopathy: the potential role of impaired cerebrovascular Aβ clearance. Ann N Y Acad Sci, 903, 180-6(2000) (Pubitemid 30251557)
15. Deane, R., Z. Wu, A. Sagare, J. Davis, S. Du Yan, K. Hamm, F. Xu, M. Parisi, B. LaRue, H. W. Hu, P. Spijkers, H. Guo, X. Song, P. J. Lenting, W. E. Van Nostrand & B. V. Zlokovic: LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms. Neuron, 43, 333-44(2004) (Pubitemid 39061126)
16. Ito, S., S. Ohtsuki & T. Terasaki: Functional characterization of the brain-to-blood efflux clearance of human amyloid-β peptide (1-40) across the rat blood-brain barrier. Neurosci Res, 56, 246-52(2006) (Pubitemid 44572534)
17. Shibata, M., S. Yamada, S. R. Kumar, M. Calero, J. Bading, B. Frangione, D. M. Holtzman, C. A. Miller, D. K. Strickland, J. Ghiso & B. V. Zlokovic: Clearance of Alzheimer's amyloid-ss (1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest, 106, 1489-99(2000) (Pubitemid 32038587)
18. Herzig, M. C., W. E. Van Nostrand & M. Jucker: Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models. Brain Pathol, 16, 40-54(2006)
19. Herzig, M. C., D. T. Winkler, P. Burgermeister, M. Pfeifer, E. Kohler, S. D. Schmidt, S. Danner, D. Abramowski, C. Sturchler-Pierrat, K. Burki, S. G. van Duinen, M. L. Maat-Schieman, M. Staufenbiel, P. M. Mathews & M. Jucker: Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat Neurosci, 7, 954-60(2004) (Pubitemid 39129504)
20. Belza, M. G. & H. Urich: Cerebral amyloid angiopathy in Down's syndrome. Clin Neuropathol, 5, 257-60(1986) (Pubitemid 17216117)
21. Donahue, J. E., J. S. Khurana & L. S. Adelman: Intracerebral hemorrhage in two patients with Down's syndrome and cerebral amyloid angiopathy. Acta Neuropathol (Berl), 95, 213-6(1998) (Pubitemid 28076019)
22. Rovelet-Lecrux, A., D. Hannequin, G. Raux, N. Le Meur, A. Laquerriere, A. Vital, C. Dumanchin, S. Feuillette, A. Brice, M. Vercelletto, F. Dubas, T. Frebourg & D. Campion: APP locus duplication causes autosomal dominant early-onset alzheimer disease with cerebral amyloid angiopathy. Nat Genet, 38, 24-6(2006) (Pubitemid 43011878)
23. Cabrejo, L., L. Guyant-Marechal, A. Laquerriere, M. Vercelletto, F. DelaFourniere, C. Thomas-Anterion, C. Verny, F. Letournel, F. Pasquier, A. Vital, F. Checler, T. Frebourg, D. Campion & D. Hannequin: Phenotype associated with APP duplication in five families. Brain, 129, 2966-76(2006) (Pubitemid 44684517)
24. Tyler, S. J., D. Dawbarn, G. K. Wilcock & S. J. Allen: alpha-and beta-secretase: profound changes in Alzheimer's disease. Biochem Biophys Res Commun, 299, 373-6(2002) (Pubitemid 35365637)
25. Stockley, J. H. & C. O'Neill: The proteins BACE1 and BACE2 and β-secretase activity in normal and Alzheimer's disease brain. Biochem Soc Trans, 35, 574-6(2007) (Pubitemid 46975079)
26. Stockley, J. H., R. Ravid & C. O'Neill: Altered β-secretase enzyme kinetics and levels of both BACE1 and BACE2 in the Alzheimer's disease brain. FEBS Lett, 580, 6550-60(2006) (Pubitemid 44827012)
27. Zhao, J., Y. Fu, M. Yasvoina, P. Shao, B. Hitt, T. O'Connor, S. Logan, E. Maus, M. Citron, R. Berry, L. Binder & R. Vassar: β-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis. J Neurosci, 27, 3639-49(2007) (Pubitemid 46557686)
28. Zhang, E. T., H. K. Richards, S. Kida & R. O. Weller: Directional and compartmentalised drainage of interstitial fluid and cerebrospinal fluid from the rat brain. Acta Neuropathol (Berl), 83, 233-9(1992)
29. Carare-Nnadi, R., M. Bernardes-Silva, M. Subash, V. H. Perry & R. O. Weller: Connections between perivascular interstitial fluid drainage pathways in the brain: Significance for Alzheimer's disease and neuroimmunology. Neuropathol Appl Neurobiol, 32, 223-223(2006)
30. Weller, R. O., S. Kida & E. T. Zhang: Pathways of fluid drainage from the brain-morphological aspects and immunological significance in rat and man. Brain Pathol, 2, 277-84(1992)
31. Schley, D., R. Carare-Nnadi, C. P. Please, V. H. Perry & R. O. Weller: Mechanisms to explain the reverse perivascular transport of solutes out of the brain. J Theor Biol, 238, 962-74(2006) (Pubitemid 43175842)
32. Weller, R. O., A. Massey, Y. M. Kuo & A. E. Roher: Cerebral amyloid angiopathy: accumulation of Aβ in interstitial fluid drainage pathways in Alzheimer's disease. Ann N Y Acad Sci, 903, 110-7(2000) (Pubitemid 30251546)
33. Weller, R. O., A. Massey, T. A. Newman, M. Hutchings, Y. M. Kuo & A. E. Roher: Cerebral amyloid angiopathy: amyloid β accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol, 153, 725-33(1998) (Pubitemid 28419027)
34. Weller, R. O. & J. A. Nicoll: Cerebral amyloid angiopathy: pathogenesis and effects on the ageing and Alzheimer brain. Neurol Res, 25, 611-6(2003) (Pubitemid 37087605)
35. Weller, R. O., H. Y. Yow, S. D. Preston, I. Mazanti & J. A. Nicoll: Cerebrovascular disease is a major factor in the failure of elimination of Abeta from the aging human brain: implications for therapy of Alzheimer's disease. Ann N Y Acad Sci, 977, 162-8(2002) (Pubitemid 35418150)
36. Bell, R. D., A. P. Sagare, A. E. Friedman, G. S. Bedi, D. M. Holtzman, R. Deane & B. V. Zlokovic: Transport pathways for clearance of human Alzheimer's amyloid β-peptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow Metab, 27, 909-18(2007) (Pubitemid 46659038)
37. Donahue, J. E., S. L. Flaherty, C. E. Johanson, J. A. Duncan, 3rd, G. D. Silverberg, M. C. Miller, R. Tavares, W. Yang, Q. Wu, E. Sabo, V. Hovanesian & E. G. Stopa: RAGE, LRP-1, and amyloid-β protein in Alzheimer's disease. Acta Neuropathol (Berl), 112, 405-15(2006) (Pubitemid 44469161)
38. Llorente-Cortes, V., J. Martinez-Gonzalez & L. Badimon: LDL receptor-related protein mediates uptake of aggregated LDL in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol, 20, 1572-9(2000) (Pubitemid 30353890)
39. Peress, N. S. & E. Perillo: Differential expression of TGF-β 1, 2 and 3 isotypes in Alzheimer's disease: a comparative immunohistochemical study with cerebral infarction, aged human and mouse control brains. J Neuropathol Exp Neurol, 54, 802-11(1995)
40. van der Wal, E. A., F. Gomez-Pinilla & C. W. Cotman: Transforming growth factor-beta 1 is in plaques in Alzheimer and Down pathologies. Neuroreport, 4, 69-72(1993) (Pubitemid 23066393)
41. Chao, C. C., S. Hu, W. H. Frey, 2nd, T. A. Ala, W. W. Tourtellotte & P. K. Peterson: Transforming growth factor β in Alzheimer's disease. Clin Diagn Lab Immunol, 1, 109-10(1994) (Pubitemid 2036309)
42. Wyss-Coray, T., E. Masliah, M. Mallory, L. McConlogue, K. Johnson-Wood, C. Lin & L. Mucke: Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease. Nature, 389, 603-6(1997) (Pubitemid 27446177)
43. Wyss-Coray, T., C. Lin, D. von Euw, E. Masliah, L. Mucke & P. Lacombe: Alzheimer's disease-like cerebrovascular pathology in transforming growth factor-β1 transgenic mice and functional metabolic correlates. Ann N Y Acad Sci, 903, 317-23(2000) (Pubitemid 30251572)
44. Ueberham, U., E. Ueberham, M. K. Bruckner, G. Seeger, U. Gartner, H. Gruschka, R. Gebhardt & T. Arendt: Inducible neuronal expression of transgenic TGF-β1 in vivo: dissection of short-term and longterm effects. Eur J Neurosci, 22, 50-64(2005) (Pubitemid 41059971)
45. Wyss-Coray, T., C. Lin, F. Yan, G. Q. Yu, M. Rohde, L. McConlogue, E. Masliah & L. Mucke: TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice. Nat Med, 7, 612-8(2001) (Pubitemid 32448330)
46. Scolding, N. J., F. Joseph, P. A. Kirby, I. Mazanti, F. Gray, J. Mikol, D. Ellison, D. A. Hilton, T. L. Williams, J. M. MacKenzie, J. H. Xuereb & S. Love: Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain, 128, 500-15(2005) (Pubitemid 40380186)
47. Nicoll, J. A., D. Wilkinson, C. Holmes, P. Steart, H. Markham & R. O. Weller: Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report. Nature Medicine, 9, 448-52(2003) (Pubitemid 36460079)
48. Boche, D., J. A. Nicoll & R. O. Weller: Immunotherapy for Alzheimer's disease and other dementias. Curr Opin Neurol, 18, 720-5(2005) (Pubitemid 41669147)
49. Nicoll, J. A., E. Barton, D. Boche, J. W. Neal, I. Ferrer, P. Thompson, C. Vlachouli, D. Wilkinson, A. Bayer, D. Games, P. Seubert, D. Schenk & C. Holmes: Aβ species removal after Aβ42 immunization. J Neuropathol Exp Neurol, 65, 1040-8(2006)
50. Howell, S., J. Nalbantoglu & P. Crine: Neutral endopeptidase can hydrolyze β-amyloid (1-40) but shows no effect on β-amyloid precursor protein metabolism. Peptides, 16, 647-52(1995)
51. Takaki, Y., N. Iwata, S. Tsubuki, S. Taniguchi, S. Toyoshima, B. Lu, N. P. Gerard, C. Gerard, H. J. Lee, K. Shirotani & T. C. Saido: Biochemical identification of the neutral endopeptidase family member responsible for the catabolism of amyloid β peptide in the brain. J Biochem (Tokyo), 128, 897-902(2000) (Pubitemid 32011559)
52. Kanemitsu, H., T. Tomiyama & H. Mori: Human neprilysin is capable of degrading amyloid β peptide not only in the monomeric form but also the pathological oligomeric form. Neurosci Lett, 350, 113-6(2003) (Pubitemid 37101425)
53. Tsubuki, S., Y. Takaki & T. C. Saido: Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of Aβ to physiologically relevant proteolytic degradation. Lancet, 361, 1957-8(2003) (Pubitemid 36694587)
54. Farris, W., S. G. Schutz, J. R. Cirrito, G. M. Shankar, X. Sun, A. George, M. A. Leissring, D. M. Walsh, W. Q. Qiu, D. M. Holtzman & D. J. Selkoe: Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy. Am J Pathol (2007)
55. Miners, J. S., Z. Van Helmond, K. Chalmers, G. Wilcock, S. Love & P. G. Kehoe: Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy. J Neuropathol Exp Neurol, 65, 1012-21(2006) (Pubitemid 44521802)
56. Carpentier, M., Y. Robitaille, L. DesGroseillers, G. Boileau & M. Marcinkiewicz: Declining expression of neprilysin in Alzheimer disease vasculature: possible involvement in cerebral amyloid angiopathy. J Neuropathol Exp Neurol, 61, 849-56(2002)
57. Eckman, E. A. & C. B. Eckman: Aβ-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention. Biochem Soc Trans, 33, 1101-5(2005) (Pubitemid 41659123)
58. Eckman, E. A., D. K. Reed & C. B. Eckman: Degradation of the Alzheimer's amyloid β peptide by endothelin-converting enzyme. J Biol Chem, 276, 24540-8(2001)
59. Weeraratna, A. T., A. Kalehua, I. Deleon, D. Bertak, G. Maher, M. S. Wade, A. Lustig, K. G. Becker, W. Wood, 3rd, D. G. Walker, T. G. Beach & D. D. Taub: Alterations in immunological and neurological gene expression patterns in Alzheimer's disease tissues. Exp Cell Res, 313, 450-61(2007) (Pubitemid 46186300)
60. Lynch, J. A., A. M. George, P. B. Eisenhauer, K. Conn, W. Gao, I. Carreras, J. M. Wells, A. McKee, M. D. Ullman & R. E. Fine: Insulin degrading enzyme is localized predominantly at the cell surface of polarized and unpolarized human cerebrovascular endothelial cell cultures. J Neurosci Res, 83, 1262-70(2006) (Pubitemid 43668009)
61. Kehoe, P. G., H. Katzov, L. Feuk, A. M. Bennet, B. Johansson, B. Wiman, U. de Faire, N. J. Cairns, G. K. Wilcock, A. J. Brookes, K. Blennow & J. A. Prince: Haplotypes extending across ACE are associated with Alzheimer's disease. Hum Mol Genet, 12, 859-67(2003) (Pubitemid 36504028)
62. Bjork, B. F., H. Katzov, P. Kehoe, L. Fratiglioni, B. Winblad, J. A. Prince & C. Graff: Positive association between risk for late-onset alzheimer disease and genetic variation in IDE. Neurobiol Aging, 28, 1374-80(2007) (Pubitemid 47081238)
63. Blomqvist, M. E., K. Chalmers, N. Andreasen, N. Bogdanovic, G. K. Wilcock, N. J. Cairns, L. Feuk, A. J. Brookes, S. Love, K. Blennow, P. G. Kehoe & J. A. Prince: Sequence variants of IDE are associated with the extent of β-amyloid deposition in the Alzheimer's disease brain. Neurobiol Aging, 26, 795-802(2005) (Pubitemid 40249481)
64. Morelli, L., R. E. Llovera, I. Mathov, L. F. Lue, B. Frangione, J. Ghiso & E. M. Castano: Insulindegrading enzyme in brain microvessels: proteolysis of amyloid β vasculotropic variants and reduced activity in cerebral amyloid angiopathy. J Biol Chem, 279, 56004-13(2004) (Pubitemid 40066608)
65. Eckman, E. A., M. Watson, L. Marlow, K. Sambamurti & C. B. Eckman: Alzheimer's disease β-amyloid peptide is increased in mice deficient in endothelin-converting enzyme. J Biol Chem, 278, 2081-4(2003) (Pubitemid 36801269)
66. Eckman, E. A., S. K. Adams, F. J. Troendle, B. A. Stodola, M. A. Kahn, A. H. Fauq, H. D. Xiao, K. E. Bernstein & C. B. Eckman: Regulation of steadystate β-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensinconverting enzyme. J Biol Chem, 281, 30471-8(2006) (Pubitemid 44582103)
67. Xu, D., N. Emoto, A. Giaid, C. Slaughter, S. Kaw, D. de Wit & M. Yanagisawa: ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell, 78, 473-85(1994) (Pubitemid 24250811)
68. Hemming, M. L. & D. J. Selkoe: Amyloid betaprotein is degraded by cellular angiotensinconverting enzyme (ACE) and elevated by an ACE inhibitor. J Biol Chem, 280, 37644-50(2005) (Pubitemid 41642372)
69. Hu, J., A. Igarashi, M. Kamata & H. Nakagawa: Angiotensin-converting enzyme degrades Alzheimer amyloid β-peptide (Aβ) ; retards Aβ aggregation, deposition, fibril formation; and inhibits cytotoxicity. J Biol Chem, 276, 47863-8(2001)
70. Oba, R., A. Igarashi, M. Kamata, K. Nagata, S. Takano & H. Nakagawa: The N-terminal active centre of human angiotensin-converting enzyme degrades Alzheimer amyloid β-peptide. Eur J Neurosci, 21, 733-40(2005) (Pubitemid 40363508)
71. Kehoe, P. G., C. Russ, S. McIlory, H. Williams, P. Holmans, C. Holmes, D. Liolitsa, D. Vahidassr, J. Powell, B. McGleenon, M. Liddell, R. Plomin, K. Dynan, N. Williams, J. Neal, N. J. Cairns, G. Wilcock, P. Passmore, S. Lovestone, J. Williams & M. J. Owen: Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease. Nat Genet, 21, 71-2(1999) (Pubitemid 29036286)
72. Lehmann, D. J., M. Cortina-Borja, D. R. Warden, A. D. Smith, K. Sleegers, J. A. Prince, C. M. van Duijn & P. G. Kehoe: Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease. Am J Epidemiol, 162, 305-17(2005) (Pubitemid 41389712)
73. Lendon, C. L., U. Thaker, J. M. Harris, A. M. McDonagh, J. C. Lambert, M. C. Chartier-Harlin, T. Iwatsubo, S. M. Pickering-Brown & D. M. Mann: The angiotensin 1-converting enzyme insertion (I)/deletion (D) polymorphism does not influence the extent of amyloid or tau pathology in patients with sporadic Alzheimer's disease. Neurosci Lett, 328, 314-8(2002) (Pubitemid 34876673)
74. Miners, J., E. Ashby, Z. Van Helmond, K. Chalmers, L. Palmer, G. Wilcock, S. Love & P. Kehoe: ACE levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy. Neuropathol Appl Neurobiol, in press
75. LePage, R. N., A. J. Fosang, S. J. Fuller, G. Murphy, G. Evin, K. Beyreuther, C. L. Masters & D. H. Small: Gelatinase A possesses a β-secretase-like activity in cleaving the amyloid protein precursor of Alzheimer's disease. FEBS Lett, 377, 267-70(1995)
76. Roher, A. E., T. C. Kasunic, A. S. Woods, R. J. Cotter, M. J. Ball & R. Fridman: Proteolysis of Aβ peptide from Alzheimer disease brain by gelatinase A. Biochem Biophys Res Commun, 205, 1755-61(1994)
77. White, A. R., T. Du, K. M. Laughton, I. Volitakis, R. A. Sharples, M. E. Xilinas, D. E. Hoke, R. M. Holsinger, G. Evin, R. A. Cherny, A. F. Hill, K. J. Barnham, Q. X. Li, A. I. Bush & C. L. Masters: Degradation of the Alzheimer disease amyloid β-peptide by metal-dependent up-regulation of metalloprotease activity. J Biol Chem, 281, 17670-80(2006) (Pubitemid 44035565)
78. Backstrom, J. R., G. P. Lim, M. J. Cullen & Z. A. Tokes: Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the β-beta peptide (1-40). J Neurosci, 16, 7910-9(1996) (Pubitemid 26405054)
79. Backstrom, J. R., C. A. Miller & Z. A. Tokes: Characterization of neutral proteinases from Alzheimer-affected and control brain specimens: identification of calcium-dependent metalloproteinases from the hippocampus. J Neurochem, 58, 983-92(1992)
80. Baig, S., P. Kehoe & S. Love: MMP-2,-3 and-9 levels and activity are not related to Aβ load in the frontal cortex in Alzheimer's disease. Neuropathol Appl Neurobiol, in press
81. Exley, C. & O. V. Korchazhkina: Plasmin cleaves Aβ42 in vitro and prevents its aggregation into β-pleated sheet structures. Neuroreport, 12, 2967-70(2001) (Pubitemid 32882017)
82. Ledesma, M. D., J. S. Da Silva, K. Crassaerts, A. Delacourte, B. De Strooper & C. G. Dotti: Brain plasmin enhances APP alpha-cleavage and Aβ degradation and is reduced in Alzheimer's disease brains. EMBO Rep, 1, 530-5(2000)
83. Melchor, J. P., R. Pawlak & S. Strickland: The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-β (Aβ) degradation and inhibits Aβ-induced neurodegeneration. J Neurosci, 23, 8867-71(2003) (Pubitemid 37210899)
84. Olichney, J. M., L. A. Hansen, D. Galasko, T. Saitoh, C. R. Hofstetter, R. Katzman & L. J. Thal: The apolipoprotein E ε4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology, 47, 190-6(1996) (Pubitemid 26243882)
85. Warzok, R. W., C. Kessler, G. Apel, A. Schwarz, R. Egensperger, D. Schreiber, E. W. Herbst, E. Wolf, R. Walther & L. C. Walker: Apolipoprotein E4 promotes incipient Alzheimer pathology in the elderly. Alzheimer Dis Assoc Disord, 12, 33-9(1998) (Pubitemid 29108160)
86. Thal, D. R., E. Ghebremedhin, U. Rub, H. Yamaguchi, K. D. Tredici & H. Braak: Two types of sporadic cerebral amyloid angiopathy. J Neuropathol Exp Neurol, 61, 282-93(2002) (Pubitemid 34212603)
87. Fryer, J. D., K. Simmons, M. Parsadanian, K. R. Bales, S. M. Paul, P. M. Sullivan & D. M. Holtzman: Human apolipoprotein E4 alters the amyloid-β40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model. J Neurosci, 25, 2803-10(2005) (Pubitemid 40389238)
88. Itoh, Y. & M. Yamada: Cerebral amyloid angiopathy in the elderly: the clinicopathological features, pathogenesis, and risk factors. J Med Dent Sci, 44, 11-9(1997) (Pubitemid 127705654)
89. Itoh, Y., M. Yamada, N. Suematsu, M. Matsushita & E. Otomo: Influence of apolipoprotein E genotype on cerebral amyloid angiopathy in the elderly. Stroke, 27, 216-8(1996) (Pubitemid 26044489)
90. Yamada, M., Y. Itoh, N. Suematsu, M. Matsushita & E. Otomo: Lack of an association between apolipoprotein E ε4 and cerebral amyloid angiopathy in elderly Japanese. Ann Neurol, 39, 683-4(1996) (Pubitemid 26143610)
91. Greenberg, S. M., M. E. Briggs, B. T. Hyman, G. J. Kokoris, C. Takis, D. S. Kanter, C. S. Kase & M. S. Pessin: Apolipoprotein E ε4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. Stroke, 27, 1333-7(1996) (Pubitemid 26286163)
92. O'Donnell, H. C., J. Rosand, K. A. Knudsen, K. L. Furie, A. Z. Segal, R. I. Chiu, D. Ikeda & S. M. Greenberg: Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med, 342, 240-5(2000) (Pubitemid 30058955)
93. Garcia, C., T. Pinho e Melo, L. Rocha & M. C. Lechner: Cerebral hemorrhage and apoE. J Neurol, 246, 830-4(1999) (Pubitemid 29467161)
94. Greenberg, S. M., G. W. Rebeck, J. P. Vonsattel, T. Gomez-Isla & B. T. Hyman: Apolipoprotein E ε4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol, 38, 254-9(1995)
95. Nicoll, J. A., C. Burnett, S. Love, D. I. Graham, D. Dewar, J. W. Ironside, J. Stewart & H. V. Vinters: High frequency of apolipoprotein E ε2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol, 41, 716-21(1997) (Pubitemid 27249176)
96. Greenberg, S. M., J. P. Vonsattel, A. Z. Segal, R. I. Chiu, A. E. Clatworthy, A. Liao, B. T. Hyman & G. W. Rebeck: Association of apolipoprotein E ε2 and vasculopathy in cerebral amyloid angiopathy. Neurology, 50, 961-5(1998) (Pubitemid 28212822)
97. McCarron, M. O., J. A. Nicoll, J. Stewart, G. M. Cole, F. Yang, J. W. Ironside, D. M. Mann, S. Love & D. I. Graham: Amyloid β-protein length and cerebral amyloid angiopathy-related haemorrhage. Neuroreport, 11, 937-40(2000) (Pubitemid 30235432)
98. Leung, C. H., W. S. Poon, L. M. Yu, G. K. Wong & H. K. Ng: Apolipoprotein E genotype and outcome in aneurysmal subarachnoid hemorrhage. Stroke, 33, 548-52(2002) (Pubitemid 34123404)
99. Niskakangas, T., J. Ohman, M. Niemela, E. Ilveskoski, T. A. Kunnas & P. J. Karhunen: Association of apolipoprotein E polymorphism with outcome after aneurysmal subarachnoid hemorrhage: a preliminary study. Stroke, 32, 1181-4(2001) (Pubitemid 32825806)
100. McCarron, M. O., K. L. Hoffmann, D. M. De Long, L. Gray, A. M. Saunders & M. J. Alberts: Intracerebral hemorrhage outcome: apolipoprotein E genotype, hematoma, and edema volumes. Neurology, 53, 2176-2179(1999)
101. McCarron, M. O., C. J. Weir, K. W. Muir, K. L. Hoffmann, C. Graffagnino, J. A. Nicoll, K. R. Lees & M. J. Alberts: Effect of apolipoprotein E genotype on in-hospital mortality following intracerebral haemorrhage. Acta Neurologica Scandinavica, 107, 106-9(2003) (Pubitemid 36286798)
102. Hamaguchi, T., S. Okino, N. Sodeyama, Y. Itoh, A. Takahashi, E. Otomo, M. Matsushita, H. Mizusawa & M. Yamada: Association of a polymorphism of the transforming growth factor-β1 gene with cerebral amyloid angiopathy. J Neurol Neurosurg Psychiatry, 76, 696-9(2005) (Pubitemid 40569681)
103. Yamada, M., N. Sodeyama, Y. Itoh, A. Takahashi, E. Otomo, M. Matsushita & H. Mizusawa: Association of neprilysin polymorphism with cerebral amyloid angiopathy. Journal of Neurology, Neurosurgery & Psychiatry, 74, 749-51(2003) (Pubitemid 36628287)
104. Christoforidis, M., R. Schober & K. Krohn: Geneticmorphologic association study: association between the low density lipoprotein-receptor related protein (LRP) and cerebral amyloid angiopathy. Neuropathol Appl Neurobiol, 31, 11-9(2005) (Pubitemid 40222821)
105. Chalmers, K. A., D. Culpan, P. G. Kehoe, G. K. Wilcock, A. Hughes & S. Love: APOE promoter, ACE1 and CYP46 polymorphisms and β-amyloid in Alzheimer's disease. Neuroreport, 15, 95-8(2004) (Pubitemid 41614979)
106. Jellinger, K.: Cerebrovascular amyloidosis with cerebral hemorrhage. J Neurol, 214, 195-206(1977) (Pubitemid 8035562)
107. Okazaki, H., T. J. Reagan & R. J. Campbell: Clinicopathologic studies of primary cerebral amyloid angiopathy. Mayo Clin Proc, 54, 22-31(1979) (Pubitemid 9116377)
108. Kalyan-Raman, U. P. & K. Kalyan-Raman: Cerebral amyloid angiopathy causing intracranial hemorrhage. Ann Neurol, 16, 321-9(1984) (Pubitemid 14041767)
109. Ishii, N., Y. Nishihara & A. Horie: Amyloid angiopathy and lobar cerebral haemorrhage. J Neurol Neurosurg Psychiatry, 47, 1203-10(1984) (Pubitemid 15204534)
110. Gilles, C., J. M. Brucher, P. Khoubesserian & J. J. Vanderhaeghen: Cerebral amyloid angiopathy as a cause of multiple intracerebral hemorrhages. Neurology, 34, 730-5(1984) (Pubitemid 14107069)
111. Gilbert, J. J. & H. V. Vinters: Cerebral amyloid angiopathy: incidence and complications in the aging brain. I. Cerebral hemorrhage. Stroke, 14, 915-23(1983) (Pubitemid 14205242)
112. Ellis, R. J., J. M. Olichney, L. J. Thal, S. S. Mirra, J. C. Morris, D. Beekly & A. Heyman: Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Neurology, 46, 1592-6(1996) (Pubitemid 26185777)
113. Knudsen, K. A., J. Rosand, D. Karluk & S. M. Greenberg: Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology, 56, 537-9(2001) (Pubitemid 32172884)
114. Greenberg, S. M.: Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment. Neurology, 51, 690-4(1998) (Pubitemid 28449244)
115. Greenberg, S. M., J. P. Vonsattel, J. W. Stakes, M. Gruber & S. P. Finklestein: The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage. Neurology, 43, 2073-9(1993) (Pubitemid 23318883)
116. Mandybur, T. I.: Cerebral amyloid angiopathy: the vascular pathology and complications. J Neuropathol Exp Neurol, 45, 79-90(1986) (Pubitemid 16189845)
117. Cadavid, D., H. Mena, K. Koeller & R. A. Frommelt: Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsies. J Neuropathol Exp Neurol, 59, 768-73(2000)
118. Olichney, J. M., L. A. Hansen, C. R. Hofstetter, M. Grundman, R. Katzman & L. J. Thal: Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol, 52, 702-8(1995)
119. Bogucki, A., W. Papierz, R. Szymanska & R. Staniaszczyk: Cerebral amyloid angiopathy with attenuation of the white matter on CT scans: subcortical arteriosclerotic encephalopathy (Binswanger) in a normotensive patient. J Neurol, 235, 435-7(1988)
120. Gray, F., F. Dubas, E. Roullet & R. Escourolle: Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy. Ann Neurol, 18, 54-9(1985) (Pubitemid 15025414)
121. Imaoka, K., S. Kobayashi, S. Fujihara, K. Shimode & M. Nagasaki: Leukoencephalopathy with cerebral amyloid angiopathy: a semiquantitative and morphometric study. J Neurol, 246, 661-6(1999) (Pubitemid 29417846)
122. Shin, H. K., P. B. Jones, M. Garcia-Alloza, L. Borrelli, S. M. Greenberg, B. J. Bacskai, M. P. Frosch, B. T. Hyman, M. A. Moskowitz & C. Ayata: Agedependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. Brain, doi:10.1093/brain/awm156 (2007) (Pubitemid 47327629)
123. Haglund, M. & E. Englund: Cerebral amyloid angiopathy, white matter lesions and Alzheimer encephalopathy - a histopathological assessment. Dement Geriatr Cogn Disord, 14, 161-6(2002)
124. Chalmers, K., G. Wilcock & S. Love: Contributors to white matter damage in the frontal lobe in Alzheimer's disease. Neuropathol Appl Neurobiol, 31, 623-31(2005) (Pubitemid 41668372)
125. Erkinjuntti, T., O. Benavente, M. Eliasziw, D. G. Munoz, R. Sulkava, M. Haltia & V. Hachinski: Diffuse vacuolization (spongiosis) and arteriolosclerosis in the frontal white matter occurs in vascular dementia. Arch Neurol, 53, 325-32(1996) (Pubitemid 26110087)
126. Scheltens, P., F. Barkhof, D. Leys, E. C. Wolters, R. Ravid & W. Kamphorst: Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging. Neurology, 45, 883-8(1995)
127. Delacourte, A., A. Defossez, P. Persuy & M. C. Peers: Observation of morphological relationships between angiopathic blood vessels and degenerative neurites in Alzheimer's disease. Virchows Archiv A, Pathological Anatomy & Histopathology, 411, 199-204(1987) (Pubitemid 17108308)
128. Vidal, R., M. Calero, P. Piccardo, M. R. Farlow, F. W. Unverzagt, E. Mendez, A. Jimenez-Huete, R. Beavis, G. Gallo, E. Gomez-Tortosa, J. Ghiso, B. T. Hyman, B. Frangione & B. Ghetti: Senile dementia associated with amyloid β protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-ε4 allele. Acta Neuropathol (Berl), 100, 1-12(2000) (Pubitemid 30352862)
129. Peers, M. C., M. B. Lenders, A. Defossez, A. Delacourte & M. Mazzuca: Cortical angiopathy in Alzheimer's disease: the formation of dystrophic perivascular neurites is related to the exudation of amyloid fibrils from the
130. Dermaut, B., S. Kumar-Singh, C. De Jonghe, M. Cruts, A. Lofgren, U. Lubke, P. Cras, R. Dom, P. P. De Deyn, J. J. Martin & C. Van Broeckhoven: Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation. Brain, 124, 2383-92(2001) (Pubitemid 33134928)
131. Williams, S., K. Chalmers, G. K. Wilcock & S. Love: Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease. Neuropathol Appl Neurobiol, 31, 414-21(2005) (Pubitemid 41059862)
132. Eng, J. A., M. P. Frosch, K. Choi, G. W. Rebeck & S. M. Greenberg: Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol, 55, 250-6(2004) (Pubitemid 38167002)
133. Yamada, M., Y. Itoh, M. Shintaku, J. Kawamura, O. Jensson, L. Thorsteinsson, N. Suematsu, M. Matsushita & E. Otomo: Immune reactions associated with cerebral amyloid angiopathy. Stroke, 27, 1155-62(1996) (Pubitemid 26226947)
134. Streichenberger, N., P. Girard-Madoux, I. Verejan, J. Pialat, C. Vital & N. Kopp: Giant cell angiitis of the central nervous system with amyloid angiopathy. A case report and review of the literature. Clin Exp Pathol, 47, 311-7(1999) (Pubitemid 30041320)
135. Anders, K. H., Z. Z. Wang, M. Kornfeld, F. Gray, V. Soontornniyomkij, L. A. Reed, M. N. Hart, M. Menchine, D. L. Secor & H. V. Vinters: Giant cell arteritis in association with cerebral amyloid angiopathy: immunohistochemical and molecular studies. Hum Pathol, 28, 1237-46(1997) (Pubitemid 27492822)